Home › Graves Disease › Florida
Graves Disease clinical trials in Florida
8 studies for Graves Disease are looking for participants at sites in Florida.
Cities in Florida
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease
- Northeast Florida Endocrine & Diabetes Associates (NEFEDA) - Orange Park Location, Fleming Island
- The Center for Diabetes and Endocrine Care, Fort Lauderdale
- University of Florida Jacksonville College of Medicine, Jacksonville
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07570316Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
- Site-052, Doral
- Site-066, Fort Myers
- Site-019, Hialeah
- and 4 more
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 17, 2026 · NCT07661056Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
- Site 109, Miami Lakes
- Site 115, Palm Harbor
- Site 123, Sarasota
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07682896A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old
- DM Clinical Research, Doral
- Floridian Clinical Research - Clinitiative, Miami
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 4, 2026 · NCT07722546A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Site Number - 1029, Clearwater
- Site Number - 1055, Jacksonville
- Site Number - 1056, Jacksonville
- and 4 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 25, 2026 · NCT06727604A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Site Number - 1024, Doral
- Site Number - 1008, Hialeah
- Site Number - 1000, Miami
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 25, 2026 · NCT07018323NEXUS Study: A Study to Test Single and Multiple Doses of MER511 Given to Adults With Graves' Disease
- Site # 1101, Hollywood
- Site # 1112, Miami
- Site # 1109, Wesley Chapel
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Aug 24, 2026 · NCT07305818Study of BHV-1300 in Graves' Disease
- Site-100, Miami
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Jul 31, 2026 · NCT06980649From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.